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ABSTRACT 
 
Dendrimers have wide range of applications in industry, Pharmaceutical and medicine. 
Oxadiazole compounds also have many applications in Pharmaceutical and medicine. 
Modification of dendrimers which have many branches like –NH2 functional groups with 
heterocyclic derivatives make them capable to show variety properties. In this article, PEI-dend-
4[N[(Ts)(2-(methyl)-5-aryl-1,3,4 oxadiazole) ]] 8a-f have been synthesized from PEI (Poly 
ethylene imine) dendrimer which modified with 1,3,4 oxadiazole derivatives and investigated 
their antimicrobial activities.  
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INTRODUCTION 
 
Dendrimers are an interesting class of molecules, because they are relatively easily may 
be modified at their surface to obtain specific biological properties. Therefore by appropriate 
variation of the surface motifs, dendrimers with specific biological properties can be 
constructed and their biological properties can be modulated in endless ways. The biological 
properties of dendrimers are to a large extent determined by the nature of the surface groups, 
opening up for the possibility to specifically tailor the dendrimers for the desire biological 
effects. Dendrimers can also be synthesized to possess intrinsic biological properties that can 
be useful for treatment and other medical interventions. Dendrimers offer a range of 
advantages with respect to mediating biological effects in the living organism.  
 
Oxadiazoles and their analogues can be considered as simple membered heterocycles 
possessing one oxygen and two nitrogen atoms. 1,3,4 oxadiazoles is the only isomers not 
containing a nitrogen-oxygen bond and are thermally stable neutral aromatic molecules[1] and 
its estimated resonance energy is 167.4 KJ/mol. 1,3,4 oxadiazole are associated with potent. 
Pharmacological activity due to the presence of toxophoric linkage[2] considerable evidence 
have been accumulated to demonstrate the efficacy of 1,3,4 oxadiazoles including anti  
protelytic, analgesic[3]anti malarial, anti cetylcholine esterase[4], anti inflammatory[5][6]  
diuretic[7] [8]  , anti pyretic[9] and anti emetic activities.  
 
MATERIALS AND METHODS 
 
All the solvents and reagents were used as AR grade and used as such without further 
purification. The NMR spectra were recorded on Agilent 400 MHz spectrometer using DMSO-d6, 
CDCl3 solvents. Silica gel column chromatography was performed using Merck silica gel (100-
200 mesh) and Merck made TLC were used for reaction monitoring. 
General procedure for the synthesis of DEN-4[N[(Ts)(1,3,4 oxadiazole)]]. 
 
Dendrimer dissolved in dry DMF and added at 0oC to 60% NaH under N2 
atmosphere.1,3,4 oxadiazole dissolved in dry DMF and added to dendrimer mixture drop wise 
in 15 min. The reaction mixture heated to 80oC overnight then extracted with EtOAc and 
worked up. 
 
           1                             2                        3                     4 
 
Sheme1: i) Tosyl Chloride/MDC,TEA/RT, 2h  ii)Tolene/NaOH 20%/0
o
C, 2h 
iii)Toluene/Acetonitrile/ethylenediamine/Reflux. 
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         5a-f                           6a-f                                                                    7a-f 
 
R:a:4Me,   R:b:4Cl,  R:c:4F,  R:d:4OMe,  R:e:4Br, R:f:H                       
 
Scheme 2:  iv)Chloro acetyl chloride/THF/reflux  v) POCl3/reflux 
 
 
7a-f + 4 8a-f 
 
R:a:4Me,   R:b:4Cl,  R:c:4F,  R:d:4OMe,  R:e:4Br, R:f:H                       
 
Scheme 3: vi) DMF/NaH 60%/0
o
c/reflux. 
 
Typical procedure for the synthesis of PEI-dend-4[N[(Ts)(2-(methyl)-5-aryl-1,3,4 oxadiazole) ]] 
8a-f. 
 
Dendrimer (4),(0.2gr-0.0023 mol) dissolved in 4 ml of dry DMF was added to 60% NaH 
(14.4gr-0.6mol) in dry DMF (10ml) under nitrogen atmosphere. The reaction mixture heated to 
80oC for 4 h and cooled to 0oC.  
 
2-(Chloromethyl)-5-aryl-1,3,4 oxadiazole (7a-f),(0.2gr-0.0118mol) dissolved in 4 ml dry 
DMF and added to dendrimer solution drop wise in 15 min. The reaction mixture heated to 
80oC overnight. The completion of the reaction was monitored by TLC and after completion, 
quenched by iced water then extracted with 2x10ml EtOAc and washed with 3x20ml water and 
brine solution then passed over Na2SO4, concentrated under reduced presser to give crude 
product. The crude product was purified by column chromatography to afford 74% yield 
product. 
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DEN-4[N[(Ts)(2-(methyl)-5-(4-methylphenyl)-1,3,4 oxadiazole)]] 8a . 
1H NMR (CDCl3): 2.07(s, 1H), 2.17-2.21(t, 2H), 2.32-2.37(dd, 6H), 2.62(t, 2H), 5.10(s, 2H), 7.31-
7.41(dd, 4H), 7.62-7.64(d, 2H), 7.86-7.88(d, 2H). 
DEN-4[N[(Ts)(2-(methyl)-5-(4-Chlorophenyl)-1,3,4 oxadiazole)]] 8b . 
1H NMR (CDCl3): 2.01(s, 1H), 2.13-2.17(t, 2H), 2.31(s, 3H), 2.59(t, 2H), 5.08(s, 2H), 7.39-7.49(dd, 
4H), 7.52-7.54(d, 2H), 7.66-7.68(d, 2H). 
DEN-4[N[(Ts)(2-(methyl)-5-(4-Fluorophenyl)-1,3,4 oxadiazole)]] 8c . 
1H NMR (CDCl3): 2.03(s, 1H), 2.15-2.17(t, 2H), 2.35 (s, 3H), 2.60(t, 2H), 5.12(s, 2H), 7.38-7.48(dd, 
4H), 7.66-7.68(d, 2H), 8.62-8.64(d, 2H). 
DEN-4[N[(Ts)(2-(methyl)-5-(4-methoxyphenyl)-1,3,4 oxadiazole)]] 8d . 
1H NMR (CDCl3): 2.10(s, 1H), 2.2-2.26(t, 2H), 2.48(s, 3H), 2.69(t, 2H), 3.81(s, 3H), 5.30(s, 2H), 
7.41-7.51(dd, 4H), 7.72-7.74(d, 2H), 8.01-8.03(d, 2H). 
DEN-4[N[(Ts)(2-(methyl)-5-(4-Bromophenyl)-1,3,4 oxadiazole)]] 8e . 
1H NMR (CDCl3): 2.03(s, 1H), 2.11-2.13(t, 2H), 2.24(s, 3H), 2.58(t, 2H), 5.15(s, 2H), 7.29-7.39(dd, 
4H), 7.32-7.34(d, 2H), 7.42-7.44(d, 2H). 
DEN-4[N[(Ts)(2-(methyl)-5-(phenyl)-1,3,4 oxadiazole)]] 8f . 
1H NMR (CDCl3):  2.00(s, 1H), 2.18-2.22(t, 2H), 2.68(t, 1H), 5.11(s, 2H), 7.49-7.59(m, 5H), 7.59-
7.61(d, 2H), 8.11-8.13(d, 2H). 
 
Biology 
 
Primary Screening by Agar well diffusion method 
 
The  antibacterial  activity of the newly synthesized compounds were evaluated by agar 
well diffusion method [10]. All the microbial cultures were adjusted to 0.5 McFarland standards, 
which is visually comparable to a microbial suspension of approximately 1.5×108 CFU/ml. 20 ml 
of Muller Hinton agar media was poured into each Petri plate and plates were swabbed with 
100 ml inoculate of the test microorganisms and kept for 15 min for adsorption. Using sterile 
cork borer of 8 mm diameter, wells were bored into the seeded agar plates and these were 
loaded with a 100 µl volume with concentration of 1.0 mg/ml of each compound reconstituted 
in the dimethyl formamide (DMF). All the plates were incubated at 37 ˚C for 24 h. Antibacterial 
activity of all the synthesized compounds was evaluated by measuring the zone of growth 
inhibition against the test organisms with zone reader (Hi antibiotic zone scale). The dimethyl 
formamide (DMF) solvent and gentamicin 10µg/well (standard antibiotic) were used negative 
and positive control  respectively. The experiments were performed in triplicates. 
 
Determination of Minimum inhibitory concentration:  
 
The broth micro dilution method was used to determine the minimum inhibitory 
concentration (MIC) according to the National Committee for Clinical Laboratory Standards 
(NCCLS, 2001) [11].All tests were performed in a Mueller-Hinton broth for the bacterial strains. 
Overnight broth cultures of each strain were prepared and the final concentration in each well 
was adjusted to 2×106 CFU/ ml. Compounds were dissolved in dimethyl formamide (DMF) and 
then diluted to the highest concentration. Two-fold serial concentrations of the compounds 
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were prepared (over the range 1000–0.19 µg/ml) in a 96-well micro titer plate. In the tests, 
triphenyl tetrazolium chloride (TTC) (Aldrich Chemical Company Inc., USA) was also added to 
the culture medium as a growth indicator. The final concentration of TTC after inoculation was 
0.05%. The microbial growth was determined by the absorbance at 600 nm using a universal 
micro plate reader after incubation at 37° C for 24 h. The MIC is defined as the lowest 
concentration of the compound at which the microorganism does not demonstrate visible 
growth. 
 
Table1: Antibacterial activity data of PEI-dend-4[N[(Ts)(2-(methyl)-5-aryl-1,3,4 oxadiazole) ]] 8a-f. 
 
Compound 
No 
Zone of inhibition in mm (MIC in µg/ml) 
Test Bacteria 
Gram positive bacteria Gram negative bacteria 
Bacillus 
subtilis 
Staphylococcus 
aureus 
Staphylococcus 
epidermidis 
E.coli Xanthomonas 
campestris 
Salmonella 
typhi 
Pseudomonas 
aeruginosa 
1 Best 23(12.5) 27(6.25) 20(12.5) 18(25) 16(25) 20(12.5) 17(25.5) 
2 Mod 12(25) 15(25) - 16(25.0)  - - 
3 Low 14(25) 18(25) - - - - - 
4 Best 25(12.5) 23(12.5) 21(25) 20(25) 20(12.5) 18(25) 15(25) 
5 Low 12(50) 14(25) - 12(50) - - - 
6 Mod 18(25) 20(25) 20(12.5) 16(12.5) - - - 
Gentamicin 34(2) 32(2) 29(4) 30(4) 26(8) 28(4) 20(4) 
Nystatin ND ND ND ND ND ND ND 
“-“ : No activity  , “ND” : No determined 
 
Table 2: Antifungal activity data of PEI-dend-4[N[(Ts)(2-(methyl)-5-aryl-1,3,4 oxadiazole) ]] 8a-f. 
 
 
 
Compound No 
Zone of inhibition in mm (MIC in µg/ml) 
Test fungi 
Filamentous Yeast 
Aspergillus niger Candida albicans 
1 Best 16(6.25) 18(6.25) 
2 Mod - 14(12.5) 
3 Low - 12(25) 
4 Best 17(6.25) 18(6.25) 
5 Low 14(25) - 
6 Mod - 14(25) 
Gentamicin ND ND 
Nystatin 18(6.25) 20(6.25) 
“-“ : No activity  , “ND” : No determined 
 
RESULTS AND DISCUSSION 
 
Chemistry 
 
The desired compounds 8a-f  were  synthesized as outlined in the scheme3. Compounds 
8a-f were synthesized by introducing heterocyclic compounds 7a-f (scheme2) to dendrimer 4 
(scheme1). 
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The dendrimer 4 was synthesized has shown in the scheme 1. 
 
i) A solution of 2-Chloroethylamine hydrochloride was dissolved in dichloro methane (MDC) and 
added drop wise to a solution of p-methyl tosylchloride (Ts-Cl) dissolved in MDC and TEA at 0o C 
then stirred for 2 hour in room temperature. The solid Chloroethylamine tosylate (ClEtNHTs) 
was collected by suction filtration and washed with distilled water and dried in vacuum. 
ii) ClEtNHTs was dissolved in toluene and a solution of NaOH added drop wise in a ice/salt bath. 
The reaction mixture stirred for 2 h then white solid tosyl aziridine collected and washed with 
distilled water and dried with vacuum. 
iii) Tosyl aziridine dissolved in toluene and acetonitrile and a solution of ethylenediamine which 
dissolved in acetonitrile drop wise added to tosyl aziridine solution, then refluxed at 60o C 
overnight. The reaction mixture cooled to room temperature and the white solid collected and 
washed with acetonitrile and dried by vacuum. 
 
The heterocyclic compounds 7a-f were synthesized has shown in the scheme 2. 
 
By refluxing 85% hydrazine hydrate and aryl esters in methanol aryl acid hydrazides 5a-f 
prepared. 
iv) Aryl acid hydrazides 5a-f treated with Chloroacetylchloride in dry THF at 0
oC followed by 
refluxing for 1 h, for preparing N(Chloroacetyl)-aryl acid hydrazides 6a-f . 
v) By refluxing with phosphorous oxychloride afforded 2-(chloromethyl)-5-aryl-1,3,4 
oxadiazoles 7a-f .  
 
Modification of dendrimer has shown in the scheme3. 
 
vi) Dendrimer was dissolved in dry DMF and added at 0o C to 60% NaH under N2 
atmosphere.1,3,4 oxadiazole dissolved in dry DMF and added to dendrimer mixture drop wise 
in 15 min. The reaction mixture heated to 80o C overnight then extracted with EtOAc and 
worked up. 
 
The formation of compounds 8a-f was confirmed by 
1H NMR. The proton of –NH-Ts 
groups in dendrimer 4, (δ : 7.32), was disappeared in 8a-f and aromatic protons for compounds 
7a-f with different substitute was appeared in ( δ : 7.86-7.88 2H) for Meta protons and (δ : 7.35-
7.37 4H) for Ortho protons merged with Tosyl group protons. 
 
Biology 
 
The antimicrobial activity of compounds 8a-f was evaluated in vitro against some human 
pathogenic Gram positive bacteria such Bacillus subtilis (MTCC 121), Staphylococcus epidermis 
(MTCC 435), Staphylococcus aureus (MTCC 7433) and Gram negative bacteria E.Coli (MTCC 
7440), Xanthomonas campestris (MTCC 7408), salmonella typhi (MTCC 733), Pseudomonas 
aeruginosa. Also compounds 8a-f were evaluated against fiamatory fungi such as aspergillus 
niger (MTCC 378) and yeast Candida albicans (MTCC 183).The corresponding zone of inhibition 
and minimum inhibitory concentrations were summarized in tables 1 and 2. 
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Results indicate that the compounds No: 1, 8d and No: 4, 8a have exhibited broad 
spectrum antimicrobial activity against both bacteria and fungi. Whereas that the rest of the 
compounds in the series have exhibited moderate antimicrobial activity when compared to 
positive controls. Antimicrobial spectrum indicates that the gram positive bacteria and fungi 
were more susceptible to the synthesized compounds than gram negative bacteria. The 
thorough investigation of our synthesized compounds 8a-f  pertaining to quantitative structure 
activity relationship highlighted that presence of more electron donating groups at Para 
position in phenyl ring bearing oxadiazole has influenced the antimicrobial activity, while it 
counterpart electron withdrawing groups has shown ins opposite effect. The compound No: 2, 
8b have shown moderate activity when compared to positive controls. The  un substituted  
compound No:5, 8f has shown better activity when comparing with compound No:3, 8c and 
compound No:6, 8e which has Fluorine and Bromo substituent.  
 
CONCLUSION 
 
In conclusion we have reported a facile route for the synthesis of PEI-dend-4[N[(Ts)(2-(methyl)-
5-aryl-1,3,4 oxadiazole) ]] 8a-f, from PEI (poly ethylene imine) dendrimer 4 and 2-
(chloromethyl)-5-aryl 1,3,4 oxadiazole) 7a-f.  The new molecular framework has shown broad 
spectrum antimicrobial activity which is substantiated by the presence of electron donating 
groups. Among the synthesized compounds 8a-f, compounds 8a and 8d has exhibited potent 
antimicrobial activity whereas the rest of the analogues have shown moderate activity when 
compared to the standard positive controls. 
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